LENZ Therapeutics Inc [LENZ] stock is trading at $37.30, up 2.90%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LENZ shares have gain 10.00% over the last week, with a monthly amount glided 32.22%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
LENZ Therapeutics Inc [NASDAQ: LENZ] stock has seen the most recent analyst activity on September 27, 2024, when Raymond James initiated its Outperform rating and assigned the stock a price target of $37. Previously, H.C. Wainwright started tracking the stock with Buy rating on August 12, 2024, and set its price target to $38. On April 15, 2024, William Blair initiated with a Outperform rating. Leerink Partners started tracking the stock assigning a Outperform rating and suggested a price target of $32 on April 15, 2024. Citigroup initiated its recommendation with a Buy and recommended $34 as its price target on April 10, 2024. Piper Sandler started tracking with a Overweight rating for this stock on March 27, 2024, and assigned it a price target of $28. In a note dated February 23, 2023, Cowen downgraded an Market Perform rating on this stock.
LENZ Therapeutics Inc [LENZ] stock has fluctuated between $10.03 and $38.93 over the past year. Currently, Wall Street analysts expect the stock to reach $34 within the next 12 months. LENZ Therapeutics Inc [NASDAQ: LENZ] shares were valued at $37.30 at the most recent close of the market. An investor can expect a potential drop of -8.85% based on the average LENZ price forecast.
Analyzing the LENZ fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -0.3 and Total Capital is -0.27.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 35.90 points at the first support level, and at 34.51 for the second support level. However, for the 1st resistance point, the stock is sitting at 38.73, and for the 2nd resistance point, it is at 40.17.
Ratios To Look Out For
For context, LENZ Therapeutics Inc’s Current Ratio is 28.63. Also, the Quick Ratio is 28.63, while the Cash Ratio stands at 5.32.
Transactions by insiders
Recent insider trading involved Chevallard Daniel R., Chief Financial Officer, that happened on May 14 ’24 when 3188.0 shares were purchased. Director, MCCOLLUM JAMES W completed a deal on May 13 ’24 to buy 31332.0 shares. Meanwhile, Director RA CAPITAL MANAGEMENT, L.P. bought 1.0 million shares on Mar 21 ’24.
